Clinical Program Leader; Radioligand therapy; RLT

Clinical Program Leader (Radioligand therapy (RLT)) Novartis
• Basel , Switzerland

6000! That's the number of associates in the Bio Medical Research (BR). This division is the innovation engine of Novartis, focusing on powerful new technologies that have the potential to help produce therapeutic breakthroughs for patients! Based on our understanding of cancer at the molecular, cellular and organismal levels, Translational Clinical Oncology or TCO will design and execute innovative exploratory clinical trials in order to develop the next generation of highly effective therapeutics that transform the lives of patients with cancer.

This role is to provide strategic medical guidance and lead the development of experimental oncology agents in the TCO portfolio, from the Phase of preclinical development, continuing through clinical First in Human and Phase 1b/2 studies.

• Acts as a clinical leader responsible for assigned global clinical program(s) - driving medical strategy implementation and operational deliverables for investigational products in a defined therapeutic area
• Ensure effective cross‑functional communications to align with global strategy and lead the development of clinical sections of trial and program‑level regulatory documents
• Act as the medical expert, engaging interactions with external stakeholders (e.g., regulatory authorities, key opinion leaders, data monitoring committees, advisory boards, etc.) and internal NVS stakeholders
• Contribute to medical/scientific training of relevant Novartis stakeholders; may serve as speaker for medical/scientific training and may serve on or lead global initiatives (e.g., process improvement, training, SOP development, other Clinical Development line function initiatives)
• Have experience leading early and/or late‑phase oncology clinical programs with radiopharmaceuticals from the pharma/biotech industry, plus credible experience from an academic medical center. If no industry experience, significant academic experience in radio‑oncology with credible PI/co‑PI clinical study leadership is required
• Track record of significant contributions to your field over time, creating new concepts and seeking out new clinical discovery opportunities and approaches